DEO vs TXMD · P/E 16, $55.86B cap vs rev $1.8M
Diageo PLC ADR (DEO) versus TherapeuticsMD Inc (TXMD) — a side-by-side from cached financials, not a winner call.
Diageo PLC ADR (DEO) is a beverages - wineries & distilleries company listed on US.
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
DEO does not have a complete income-statement cache yet.
Latest reported TXMD revenue for 2024-12-31 was $1.8M. Net income was -$2.2M. Revenue was up 35.3% from 2023-12-31 to 2024-12-31. TXMD currently screens at market cap $13.7M.
DEO currently screens at market cap $55.86B and trailing P/E 15.6. TXMD currently screens at market cap $13.7M.
Not investment advice. Open the DEO and TXMD stock pages for the full models.
Not investment advice.